Join the Breast Cancer - Adjuvant group to help and get support from people like you.
Breast Cancer - Adjuvant News (Page 11)
Nudge in EHR Can Reduce Unnecessary Sentinel Lymph Node Biopsy
THURSDAY, July 25, 2024 – A nudge intervention in the electronic health record (EHR) targeting surgeons can reduce sentinel lymph node biopsy (SLNB) among women who meet the Choosing Wisely criteria...
Disparities Persist in Postmastectomy Reconstruction
TUESDAY, July 23, 2024 – Postmastectomy reconstruction (PMR) rates among American Indian/Alaska Native (AI/AN) women with breast cancer increased from 2004 to 2017, but remain significantly lower...
Many Breast Cancer Survivors With Indications for Genetic Testing Do Not Receive It
TUESDAY, July 23, 2024 – Many breast cancer survivors with indications for genetic counseling and testing do not receive it, according to a study published online July 15 in the Journal of Clinical ...
Too Many Breast Cancer Survivors Miss Out on Genetic Screening
FRIDAY, July 19, 2024 – Many breast cancer patients aren’t getting genetic counseling and testing that could help them get the most effective treatment, a new study finds. Only three-quarters of p...
Some Women in Their 40s Prefer to Delay Breast Cancer Screening
MONDAY, July 15, 2024 – A considerable proportion of women aged 39 to 49 years prefer to delay breast cancer screening, especially after a decision aid (DA) intervention, according to a study...
FDA Approves Genentech’s Perjeta (Pertuzumab) for Adjuvant Treatment of Specific Type of Early Breast Cancer
South San Francisco, CA – December 20, 2017 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has approved Perjeta ® ...
FDA Approves Nerlynx (neratinib) for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer
July 17, 2017 – The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type...